Home / Recalls / Nostrum Laboratories, Inc. / D-1030-2016

D-1030-2016 Class II Terminated

Recalled by Nostrum Laboratories, Inc. — Bryan, OH

Recall Details

Product Type
Drugs
Report Date
June 22, 2016
Initiation Date
May 23, 2016
Termination Date
April 28, 2017
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
2839 bottles

Product Description

Nitrofurantoin Oral Suspension, USP, 25 mg/5 mL, FOR ORAL USE ONLY, URINARY TRACT ANTIBACTERIAL, Rx Only , 240 mL bottle, Dist. by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512, Mfg. by: Sun Pharmaceutical Industries, Inc., Bryan, Ohio 43506, NDC 57664-239-32

Reason for Recall

Failed Dissolution Specifications

Distribution Pattern

Nationwide

Code Information

BZP0093A, BZP0094A, BZP0095A, BZP0096A, BZP0097A, Exp 02/2017

Other recalls by Nostrum Laboratories, Inc.

  • D-0547-2025 Class II — Sucralfate Tablets, USP 1 gram, packaged in a) 100-count bottles NDC 29033-0003- (July 11, 2025)
  • D-0249-2021 Class II — Metformin Hydrochloride Extended-Release Tablets, USP, 750 mg, 100 Tablets per b (January 25, 2021)
  • D-0227-2021 Class II — Metformin Hydrochloride Extended-Release Tablets, USP, 750 mg, 100 tablets per b (January 4, 2021)
  • D-0068-2021 Class II — Metformin Hydrochloride Extended-Release Tablets, USP 500 mg, 100 count bottles, (October 23, 2020)
  • D-0067-2021 Class II — Metformin Hydrochloride Extended-Release Tablets, USP 750 mg, 100 count bottles, (October 23, 2020)
  • D-1059-2020 Class II — Theophylline (Anhydrous) Extended-Release Tablets, 400 mg, 100-count bottle, Rx (March 6, 2020)
  • D-0473-2018 Class III — Calcium Acetate Capsules, 667 mg, 200 Capsules per bottle, Rx Only. Manufacture (February 13, 2018)